Emergency Department Registered Nurses’ Perceptions of Substance Use Disorders and Supervised Consumption Sites
DOI:
https://doi.org/10.29173/cjen234Keywords:
harm reduction, emergency department, emergency nurses, supervised consumption sites, substance use disorderAbstract
Abstract
Background: Canada is facing increased drug-related harms; thus, a stronger emphasis has been placed on harm reduction strategies such as supervised consumption sites (SCSs). There is a lack of literature on emergency department (ED) registered nurses' (RNs) perceptions of SCSs and substance use disorders (SUDs), especially in small to mid-sized Canadian cities.
Purpose: This study aimed to determine ED RNs’ perceptions of SUDs and SCSs.
Methods: A 27-question survey was sent to RNs currently working in EDs in Southwestern Ontario using an online Qualtrics® link. The research explored ED RNs’ perceptions of SCSs and SUDs.
Results: Quantitative results indicated that ED RNs (n = 146) were understanding of drug use and SUDs but felt neutral towards SCSs. They indicated positive impacts and potential concerns of SCS implementation. However, most ED RNs reported that they would still refer their patients to such sites if one was available, despite their apprehensions.
Conclusion: This research demonstrates the importance of harm reduction education in nursing curricula and the workplace. Recommendations include a harm reduction referral partnership between the ED and community partners. It is essential to practice reflectively, decrease the influence of stereotypes and stigma-based decisions and care, and encourage legislation that supports ethical policies and procedures that increase the use and access to SCSs.
References
Arabaci, L. B. (2016). Perceptions and attitudes of nurses working at emergency unit about the causes and treatment of addiction. Journal of Psychiatric Nursing, 7(3),105-113. https://doi.org/h8nt
Bayoumi, A. M., & Zaric, G. S. (2008). The cost-effectiveness of Vancouver’s supervised injection facility. Canadian Medical Association Journal, 179(11), 1143–1151. https://www.cmaj.ca/content/179/11/1143
Behrends, C. N., Paone, D., Nolan, M. L., Tuazon, E., Murphy, S. M., Kapadia, S. N., Jeng, P. J., Bayoumi, A. M., Kunins, H. V., & Schackman, B. R. (2019). Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City. Journal of Substance Abuse Treatment, 106, 79-88. https://doi.org/gmx3r5
Chu, C. & Galang, A. (2013, June 1). Hospital nurses’ attitudes toward patients with a history of illicit drug use. Canadian nurse.
Enns, E. A., Zaric, G. S., Strike, C. J., Jairam, J. A., Kolla, G., & Bayoumi, A. M. (2016). Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada. Addiction,111(3), 475–489. https://doi.org/hsmb
Eysenbach, G., & Wyatt, J. (2002). Using the internet for surveys and health research. Journal of Medical Internet Research, 4(2). https://doi.org/10.2196/jmir.4.2.e13
Global State of Harm Reduction. (2018). Global overview.
https://www.hri.global/files/2018/12/10/GlobalOverview-harm-reduction.pdf
Government of Canada. (2021, July 22). Supervised consumption sites and services: Explained. https://www.canada.ca/en/health-canada/services/substance-use/supervised-consumption-sites/explained.html
Government of Canada. (2022, June 23). Opioid- and stimulant-related harms in Canada. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/
Harm Reduction International. (2020). Global state of harm reduction 2020 7th edition. https://www.hri.global/files/2021/03/04/Global_State_HRI_2020_BOOK_FA_Web.pdf
Hawk, K., & D’Onofrio, G. (2018). Emergency department screening and interventions for substance use disorders. Addiction Science & Clinical Practice, 13, 1-6. https://doi.org/gkzgc2
Hayashi, K., Wood, E., Dong, H., Buxton, J. A., Fairbairn, N., DeBeck, K., Milloy, M. J., & Kerr, T. (2021). Awareness of fentanyl exposure and the associated overdose risks among people who inject drugs in a Canadian setting. Drug and Alcohol Review, 40(6), 964–973. https://doi.org/hsmc
Horner, G., Daddona, J., Burke, D. J., Cullinane, J., Skeer, M., & Wurcel, A. G. (2019). "You're kind of at war with yourself as a nurse": Perspectives of inpatient nurses on treating people who present with a comorbid opioid use disorder. Plos One, 25(10), 1-16. https://doi.org/ggh5kd
Howard, M. O., & Chung, S. S. (2000). Nurses' attitudes toward substance misusers. II. Experiments and studies comparing nurses to other groups. Substance Use & Misuse, 35(4), 503-532. https://doi.org/dtkr6r
Irvine, M. A., Kuo, M., Buxton, J. A., Balshaw, R., Otterstatter, M., Macdougall, L., Milloy, M. J., Bharmal, A., Henry, B., Tyndall, M., Coombs, D., & Gilbert, M. (2019). Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic. Addiction, 114(9), 1602–1613. https://doi.org/hsmd
Irwin, A., Jozaghi, E., Bluthenthal, R. N., & Kral, A. H. (2017). A cost-benefit analysis of a potential supervised injection facility in San Francisco, California, USA. Journal of Drug Issues, 47(2), 164–184. https://doi.org/f92zzp
Jackson, L. A., Dechman, M., Mathias, H, Gahagan, J., & Morrison, K. (2022). Safety and danger: Perceptions of the implementation of harm reduction programs in two communities in Nova Scotia, Canada. Health and Social Care in the Community,30(1), 360-371. https://doi.org/gkbjr9
Katz, N., Leonard, L., Wiesenfeld, L., Perry, J. J., Thiruganasambandamoorthy, V., & Calder, L. (2017). Support of supervised injection facilities by emergency physicians in Canada. International Journal of Drug Policy, 49, 26-31. https://doi.org/h59w
Kenney, S. R., Anderson, B. J., Bailey, G. L., Herman, D. S., Conti, M. T. & Stein, M. D. (2021). Examining overdose and homelessness as predictors of willingness to use supervised injection facilities by services provided among persons who inject drugs. The American Journal of Addictions, 30(1), 21-25. https://doi.org/gmx3r8
Kerr, T., Mitra, S., Kennedy, M. C., & McNeil, R. (2017). Supervised injection facilities in Canada: Past, present, and future. Harm Reduction Journal, 14(1), 1-9. https://doi.org/gbhgx9
Kerr, T., Small, W., Moore, D., & Wood, E. (2007). A micro-environmental intervention to reduce the harms associated with drug-related overdose: Evidence from the evaluation of Vancouver's safer injection facility. The International Journal on Drug Policy, 18(1), 37–45. https://doi.org/ckr3gt
Lange, B. C. L., & Bach-Mortesen, A., M. (2019). A systematic review of stakeholder perceptions of supervised injection facilities. Drug and Alcohol Dependence, 197, 299-314. https://doi.org/gmx3qb
Lowenstein, M., Sangha, H. K., Spadaro, A., Perrone, J., Delgado M. K., & Agarwal A. K. (2022). Patient perspectives on naloxone receipt in the emergency department: A qualitative exploration. Harm Reduction Journal, 19(97), 1-9. https://doi.org/gq7m5k
Madah-Amiri, D., Skulberg, A. K., Braarud, A. C., Dale, O., Heyerdahl, F., Lobmaier, P., & Clausen, T. (2019). Ambulance-attended opioid overdoses: An examination into overdose locations and the role of a safe injection facility. Substance Abuse, 40(3), 383–388. https://doi.org/gmx3qh
Marshall, B. D. L., Milloy, M. J., Wood, E., Montaner, J. S., & Kerr, T. (2007). Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: A retrospective population-based study. The Lancet, 377(9775), 1429-1437. https://doi.org/bb6v79
McNeil R., Small W., Wood E., & Kerr T. (2014). Hospitals as a 'risk environment': An ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs. Journal of Social Science and Medicine, 105, 59-66. https://doi.org/f5zvdp
Milloy M. S., Kerr T., Tyndall M., Montaner J., & Wood E. (2008). Estimated drug overdose
deaths averted by North America's first medically-supervised safer injection facility. Plos
One, 3(10), 1-6. https://doi.org/btrxxt
Moe, J., Wang E. Y., McGregor, M. J., Schull, M. J., Dong, K., Holroyd, B. R., Hohl, C. M., Grafstein, E., O’Sullivan, F., Trimble, J. & McGrail., K. M. (2022). People who make frequent emergency department visits based on persistence of frequent use in Ontario and Alberta: A retrospective cohort study. CMAJ Open, 10(1), E220-E231. https://doi.org/h8nw
Myer, A. J., & Belisle, L. (2018). Highs and lows: An interrupted time-series evaluation of the impact of North America’s only supervised injection facility on crime. Journal of Drug Issues, 48(1), 36–49. https://doi.org/gmx3ss
Notta, D., Black, B., Chu, T., Joe, R., & Lysyshyn, M. (2019). Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada. Drug and Alcohol Dependence, 196, 46–50. https://doi.org/gmx3rj
Olding, M., Ivsins, A., Mayer, S., Betsos, A., Boyd, J., Sutherland, C., Culbertson, C., Kerr, T., & McNeil, R. (2020). A low-barrier and comprehensive community-based harm reduction site in Vancouver, Canada. American Journal of Public Health, 110(6), 833-835. https://doi.org/gmx3p7
Pauly, B., Wallace, B., Pagan, F., Phillips, J., Wilson, M., Hobbs, H., & Connolly, J. (2020). Impact of overdose prevention sites during a public health emergency in Victoria, Canada. Plos One, 15(5), 1-18. https://doi.org/gjg29q
Registered Nurses’ Association of Ontario. (2015). Engaging clients who use substances. https://rnao.ca/sites/rnao.ca/files/Engaging_Clients_Who_Use_Substances_13_WEB.pdf
Registered Nurses’ Association of Ontario. (2018). Implementing supervised injection services. https://rnao.ca/sites/rnao-ca/files/bpg/Implementing_supervised_
injection_services.pdf
Registered Nurses’ Association of Ontario. (2022, April 2). Nurses speak out for harm reduction. https://rnao.ca/about/public-impact/harm-reduction
Salters-Pedneault, K. (2020). The use of self-report data in psychology. https://www.verywellmind.com/definition-of-self-report-425267
Shreffler, J., Shaw, I., McGee, S., Bishop, C., Thé, S., O’Brien, D., Price, T., & Huecker, M. (2021). Perceptions diverge on aspects related to substance use disorder: An analysis of individuals in recovery, physicians, nurses, and medical students. Substance Abuse, 42(4), 896-904. https://doi.org/hwjt
United Nations Office on Drugs and Crime. (2021c, June). Global overview: Drug demand drug supply. https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_2.pdf
van Boekel, L. C., Brouwers, E. P., van Weeghel, J., & Garretsen, H. F. (2013). Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review. Drug and Alcohol Dependence, 131(1-2), 23–35. https://doi.org/f47f9g
Wegner, L., Arreola, S. G., & Kral, A. H. (2011). The prospect of implementing a safer injection facility in San Francisco: Perspectives of community stakeholders. International Journal of Drug Policy, 22(3), 239-241. https://doi.org/b63955
Wood, E., Tyndall, M. W., Zhang, R., Montaner, J. S. G., & Kerr, T. (2007). Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction, 102(6), 916–919. https://doi.org/cqs53bga5
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Aleksandra Ilievska, Gina Pittman, Jody Ralph
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Canadian Journal of Emergency Nursing is published Open Access under a Creative Commons CC-BY 4.0 license. Authors retain full copyright.
